Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12CAndreas Weiss, Saskia M. Brachmann, Claudio Bomio-Confaglia et al.|Cancer Discovery|2022Cited by 134
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonistsDavid A. Sandham, Caroline Wilson, Clive Aldcroft et al.|Bioorganic & Medicinal Chemistry Letters|2007Cited by 18